Epidemiological parameter | Value | Source | Population |
Life expectancy | 57 | World Bank36 | Sub-Saharan Africa |
Crude birth rate | 37* | World Bank36 | Sub-Saharan Africa |
Infant mortality | 77† | World Bank36 | Sub-Saharan Africa |
Population | 961.5 million | World Bank36 | Sub-Saharan Africa |
NMR | 29† | World Bank36 | Sub-Saharan Africa |
% NMR attributable to NS | 17%–29% | UN IGCME37 | Sub-Saharan Africa |
Case fatality rate for NS | 50% | WHO 20053 38 | Sub-Saharan Africa |
Incidence of PIH | 3–5† | Warf et al 7 | Ugandan infants |
Risk of cerebral palsy secondary to NS | 3.2%–16.3%‡ | Consensus from the literature§ | International meta-analyses among low birthweight infants in low-income and middle-income countries |
Risk of total neurodevelopmental impairment secondary to NS | 26.4%–47.4%§ | Consensus from the literature§ | International meta-analyses among low birthweight infants in low-income and middle-income countries |
*Value per 1000 persons.
†Value per 1000 live births.
‡Range gives 95% CI reported in the literature.
§See further discussion in online supplementary materials.
DALY, daily-adjusted life year; NMR, neonatal mortality rate; NS, neonatal sepsis; PIH, postinfectious hydrocephalus; UN IGCME, United Nations Inter-agency Group for Child Mortality Estimation.